Evidence map›Paper›PMID 19395663›Full record

ArticleEukaryotic cell2009

Identification of the Candida albicans Cap1p regulon.

Sadri Znaidi, Katherine S Barker, Sandra Weber, Anne-Marie Alarco, Teresa T Liu, Geneviève Boucher, P David Rogers, Martine Raymond

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 109 citations in OpenAlex.

  1. A Novel Role of Ume6 inJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. A roadmap to chemically reactive species: how diverse oxidants affectMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  6. Integrative Phosphoproteomic and Proteomic Analysis ofJournal of proteome research · 2025
    Article
  7. Review
  8. Article
  9. Frontiers in microbiology · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Oxidative stress response pathways in fungi.Cellular and molecular life sciences : CMLS · 2022
    Review
  15. Identification of Clinical Isolates ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  16. Review
  17. Ethylzingerone, a Novel Compound with Antifungal Activity.Antimicrobial agents and chemotherapy · 2021
    Article
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sadri ZnaidiInstitute for Research in Immunology and Cancer, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montreal, Quebec, Canada H3C 3J7.
Katherine S Barker
Sandra Weber
Anne-Marie Alarco
Teresa T Liu
Geneviève Boucher
P David Rogers
Martine Raymond
University of Tennessee Health Science Center · USInstitute for Research in Immunology and Cancer · CALe Bonheur Children's Hospital · US

Funding

Novel Azole Resistance Mechanisms in Candida albicansR01AI058145 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ROGERS, P. DAVID · 2005 to 2021
$5.8M
NIAID NIH HHS R01 AI058145
6 · The paper itself

Abstract

Cap1p, a transcription factor of the basic region leucine zipper family, regulates the oxidative stress response (OSR) in Candida albicans. Alteration of its C-terminal cysteine-rich domain (CRD) results in Cap1p nuclear retention and transcriptional activation. To better understand the function of Cap1p in C. albicans, we used genome-wide location profiling (chromatin immunoprecipitation-on-chip) to identify its transcriptional targets in vivo. A triple-hemagglutinin (HA(3)) epitope was introduced at the C terminus of wild-type Cap1p (Cap1p-HA(3)) or hyperactive Cap1p with an altered CRD (Cap1p-CSE-HA(3)). Location profiling using whole-genome oligonucleotide tiling microarrays identified 89 targets bound by Cap1p-HA(3) or Cap1p-CSE-HA(3) (the binding ratio was at least twofold; P < or = 0.01). Strikingly, Cap1p binding was detected not only at the promoter region of its target genes but also at their 3' ends and within their open reading frames, suggesting that Cap1p may associate with the transcriptional or chromatin remodeling machinery to exert its activity. Overrepresented functional groups of the Cap1p targets (P < or = 0.02) included 11 genes involved in the OSR (CAP1, GLR1, TRX1, SOD1, CAT1, and others), 13 genes involved in response to drugs (PDR16, MDR1, FLU1, YCF1, FCR1, and others), 4 genes involved in phospholipid transport (PDR16, GIT1, RTA2, and orf19.932), and 3 genes involved in the regulation of nitrogen utilization (GST3, orf19.2693, and orf19.3121), suggesting that Cap1p has other cellular functions in addition to the OSR. Bioinformatic analyses of the bound sequences suggest that Cap1p recognizes the DNA motif 5'-MTKASTMA. Finally, transcriptome analyses showed that increased expression generally accompanies Cap1p binding at its targets, indicating that Cap1p functions as a transcriptional activator.

Indexed as

RegulonBasic-Leucine Zipper Transcription FactorsBinding SitesCandida albicansCell Cycle ProteinsConserved SequenceFungal ProteinsGene Expression ProfilingGene Expression Regulation, FungalProtein BindingTrans-ActivatorsBasic-Leucine Zipper Transcription FactorsCAP1 protein, Candida albicansCell Cycle ProteinsFungal ProteinsTrans-Activators

Identifiers

PMID19395663
PMCPMC2698309
OpenAlexW2164315014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.